II

Serial Number 97817022
688

Registration Progress

Application Filed
Mar 1, 2023
Under Examination
Nov 5, 2024
Approved for Publication
Sep 10, 2024
Published for Opposition
Sep 10, 2024
Registered

Basic Information

Serial Number
97817022
Filing Date
March 1, 2023
Published for Opposition
September 10, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Nov 5, 2024
Application
Pending
Classes
044

Rights Holder

BAUSCH + LOMB IRELAND LIMITED

77
Address
3013 LAKE DRIVE
CITYWEST BUSINESS CAMPUS
DUBLIN D24PPT3
IE

Ownership History

Novartis AG

Original Applicant
99
Basel CH

BAUSCH + LOMB IRELAND LIMITED

New Owner Before Publication #1
77
DUBLIN IE

BAUSCH + LOMB IRELAND LIMITED

Owner at Publication
77
DUBLIN IE

Legal Representation

Attorney
Nancy L Rowe

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

28 events
Date Code Type Description
May 2, 2025 EISU I TEAS STATEMENT OF USE RECEIVED
May 2, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 2, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 2, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 5, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 10, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 10, 2024 PUBO A PUBLISHED FOR OPPOSITION
Aug 21, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 6, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 11, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 11, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 11, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 11, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 11, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 11, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 27, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 27, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 11, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 11, 2023 CNRT R NON-FINAL ACTION WRITTEN
Dec 11, 2023 GNRT F NON-FINAL ACTION E-MAILED
Nov 30, 2023 DOCK D ASSIGNED TO EXAMINER
Nov 1, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 25, 2023 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 25, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 25, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 25, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 20, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 4, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 044
Providing medical and health care information to improve understanding about dry eye disease and its treatment

Additional Information

Pseudo Mark
TWO; 2; I I

Classification

International Classes
044